Skip to main content

Table 4 Metabolic syndrome and criteria prevalence.

From: Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

 

FE

<10 yr

10 to 20 yr

>20 yr

p

MS ATP-III

17% (17)

21.5% (28)

34.9% (37)

36.7% (29)

0.0026

Criteria:

     

Waist (M>102, F>88)

18% (18)

32.3% (42)

45.3% (48)

44.3% (42)

0.0001

BP (≥ 130/85)

43% (43)

34.6% (45)

57.5% (61)

64.7% (51)

0.0001

HDL (M<40 mg/dl, F<50 mg/dl)

26% (26)

27.7% (36)

31.1% (33)

31.6% (26)

ns

TG (≥ 150 mg/dl)

33% (33)

36.1% (47)

50.9% (54)

46.8% (37)

0.0252

Glucose (≥ 110 mg/dl)

3% (3)

2.3% (3)

11.3% (12)

20.2% (16)

0.0001

MS ATP-III A (AHA)

18% (18)

24.6% (32)

39.6% (42)

44.3% (35)

0.0001

Criteria:

     

Waist (M>102, F>88)

18% (18)

32.3% (42)

45.3% (48)

44.3% (42)

0.0001

BP (≥ 130/85)

43% (43)

34.6% (45)

57.5% (61)

64.7% (51)

0.0001

HDL (M<40 mg/dl, F<50 mg/dl)

26% (26)

27.7% (36)

31.1% (33)

31.6% (26)

ns

TG (≥ 150 mg/dl)

33% (33)

36.1% (47)

50.9% (54)

46.8% (37)

0.0252

Glucose(≥ 100 mg/dl)

8% (8)

16.9% (22)

27.4% (29)

40.5% (32)

0.0001

MS IDF

17% (17)

28.5% (37)

42.4% (45)

49.4% (39)

0.0001

Criteria:

     

Waist (M ≥ 94, F ≥ 80)

38% (38)

55.4% (72)

73.6% (78)

70.9% (56)

0.0001

BP (≥ 130/85)

43% (43)

34.6% (45)

57.5% (61)

64.7% (51)

0.0001

HDL (M<40 mg/dl, F<50 mg/dl)

26% (26)

27.7% (36)

31.1% (33)

31.6% (26)

ns

TG (≥ 150 mg/dl)

33% (33)

36.1% (47)

50.9% (54)

46.8% (37)

0.0252

Glucose (≥ 100 mg/dl)

8% (8)

16.9% (22)

27.4% (29)

40.5% (32)

0.0001